|

firmonertinib adjuvant therapy Clinical Trials

1 actively recruiting trial

Also known as: AST-2818

Pipeline

Phase 2: 1

Top Sponsors

  • Peking University Cancer Hospital & Institute1

Indications

  • EGFR Positive Non-small Cell Lung Cancer1
  • NSCLC1
  • Lung Cancer1
  • Neoadjuvant Therapy1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.